Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10391-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10391-1-AP, RRID:AB_2272775
- Product name
- UGP2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated UGP2 antibody (Cat. #10391-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references UGP2 is a potential target for breast cancer, based on bioinformatics analysis and in vitro experiments.
Discovery of a Novel Target Inhibitor Theaflavin against UDP-Glucose Pyrophosphorylase 2 and Its Role in Attenuating the Malignant Phenotype of Liver Cancer Cells via Perturbation of Glucose Metabolism.
Glucose-dependent glycosphingolipid biosynthesis fuels CD8(+) T cell function and tumor control.
MYCT1 alters the glycogen shunt by regulating selective translation of RACK1-mediated enzymes.
Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
Zhang X, Zheng Z, Chang Y, Wang Z, Han J, He J
Scientific reports 2025 Nov 26;15(1):42990
Scientific reports 2025 Nov 26;15(1):42990
Discovery of a Novel Target Inhibitor Theaflavin against UDP-Glucose Pyrophosphorylase 2 and Its Role in Attenuating the Malignant Phenotype of Liver Cancer Cells via Perturbation of Glucose Metabolism.
Zhou Y, Song N, Hu H, Wang Y, Zhao Z, Sun C, Xie S, Yu A, Xu F, Li D, Chang M, Cao H
Journal of agricultural and food chemistry 2025 Dec 17;73(50):31893-31905
Journal of agricultural and food chemistry 2025 Dec 17;73(50):31893-31905
Glucose-dependent glycosphingolipid biosynthesis fuels CD8(+) T cell function and tumor control.
Longo J, DeCamp LM, Oswald BM, Teis R, Reyes-Oliveras A, Dahabieh MS, Ellis AE, Vincent MP, Damico H, Gallik KL, Compton SE, Capan CD, Williams KS, Esquibel CR, Madaj ZB, Lee H, Roy DG, Krawczyk CM, Haab BB, Sheldon RD, Jones RG
bioRxiv : the preprint server for biology 2024 Oct 14;
bioRxiv : the preprint server for biology 2024 Oct 14;
MYCT1 alters the glycogen shunt by regulating selective translation of RACK1-mediated enzymes.
Ding DX, Wang Y, Yan W, Fu WN
iScience 2022 Mar 18;25(3):103955
iScience 2022 Mar 18;25(3):103955
Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hu Q, Shen S, Li J, Liu L, Liu X, Zhang Y, Zhou Y, Zhu W, Yu Y, Cui G
Disease markers 2020;2020:3231273
Disease markers 2020;2020:3231273
Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Zeng C, Xing W, Liu Y
Journal of cellular biochemistry 2019 Aug;120(8):12489-12499
Journal of cellular biochemistry 2019 Aug;120(8):12489-12499
Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
Kakehashi A, Ishii N, Shibata T, Wei M, Okazaki E, Tachibana T, Fukushima S, Wanibuchi H
Toxicological sciences : an official journal of the Society of Toxicology 2011 Jan;119(1):61-72
Toxicological sciences : an official journal of the Society of Toxicology 2011 Jan;119(1):61-72
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 10391-1-AP(UGP2 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The UGP2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human UGP2. This antibody recognizes human, mouse antigen. The UGP2 antibody has been validated for the following applications: ELISA, IHC, WB analysis.